MedTrace Logo

Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis

NCT03242525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2019-03-19

No results posted yet for this study

Summary

The aim of the present study is to quantify the time advantage achieved by the use of POCT compared to conventional coagulation diagnostics. A further objective of this study is an analysis of the result quality of POCT for the prothrombin time / international normalized ratio.

Conditions

  • Blood
  • Point-of-Care Systems
  • Analysis, Event History

Interventions

DIAGNOSTIC_TEST

POCT and central laboratory blood analysis

In every participant blood analysis will be performed by POCT and central laboratory investigating the time advantage.

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Kai Zacharowski, Prof. Dr. · Department of Anesthesia, Intensive Care Medicine and Pain Therapy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-26
Primary Completion
2018-11-30
Completion
2019-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242525 on ClinicalTrials.gov